Fibromyalgia syndrome;Fibromialgia

Revista Brasileira de Medicina

Volumn 58, Issue SPEC. ISS., 2001, Pages 215-224

  Antônio, Sílvio Figueira ^a  

^a Hosp do Servidor Publico E   (Brazil)

Author keywords

Fibromyalgia syndrome; Musculoskeletal pain syndromes

Indexed keywords

4 HYDROXYBUTYRIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CALCITONIN; CHLORIDE; LIDOCAINE; MALIC ACID; MUSCLE RELAXANT AGENT; OPIATE AGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL FEATURE; COGNITIVE THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FIBROMYALGIA; HUMAN; MYOFASCIAL PAIN; NOMENCLATURE; PATHOPHYSIOLOGY; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 14244270857     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Simons DG: Muscle pain syndromes - Part I. Am J Phys Med 1975; 54:289-311.
2. Bennett RM: Fibrositis: misnomer for a common rheumatic disorder. West J Med 1981; 134:405-13.
3. Stockman R: The causes, pathology and treatment of chronic rheumatism. Edinburgh Med Jour 1904; 15:107-116, 223-35.
4. a edition-chapter 84:1619-40; 1997.
5. Yunus MB; Masi AT; Calabro JJ; Miller KA & Feigenbaum SL - Primary fibromyalgia (fibrosistis): clinical study of 50 patients with matched normal controis. Sem Arthritis Rheum 1981 ; 11 (1) : 151-71.
6. Wolfe F; Smithe HA; Yunus MB; et al.- The American College of Rheumatology 1990 criteria for classification of fibromyalgia: Report of the multicentric criteria committee. Arthritis Rheum 1990; 33:160-172.
7. Wolfe F - Vancouver Fibromyalgia Consensus Group: The fibromyalgia syndrome: A consensus report on fioromyalgia and disability. J Rheumatol 1996; 23:534.
8. Winfield JF - Pain in fibromyalgia - Rheum Dis Clin North Am 1999; 25(1):55-79.
9. White K, Speechley M, Harth M, et al: The London Fibromyalcia Study: The prevalence of fibromyalgia (FMS) in London, Ontario, Arthritis Rheum 1996; 39 (suppl):212.
10. White KP, Speechley M, Harth M, et al: The London Fioromyalgia Epidemiology Study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26:1570-66.
11. Wolfe F, Ross K, Anderson J, et al: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19-28.
12. Gowin KM: Diffuse pain syndromes in the elderly. Rheum Dis Clin North Am 2000; 26(3), 673-682.
13. White KR Speechley M, Harth M, Ostbye T: Fibromyalgia in rheumatology practice: a survey of Canadian rheumatologists. J Rheumatol 1995; 22:722-726.
14. Hench PK: Evaluation and differential diagnosis of fioromyalgia. Rheum Dis Clin North Am 1989; 15(1):19-29.
15. McCain GA: A cost-effective approach to the diagnosis and treatment of fibromyalgia. Rheum Dis Clin North Am 1996; 22(2):323-49.
16. Yunus MB, Masi AT, Aldag JC: A controlled study of primary fibromyalgia syndrome. Clinical features and association with other functional syndromes. J Rheumatol 1989: 16 (suppl 19):62-71.
17. Wolfe F, Cathey MA, Kleinheksel SM et al: Psychologica. status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol 1984; 11:500-6.
18. McCain GA, Scudds RA: The concept of primary fibromyalgia: Clinical value, relation and significance to other musculoskeletal pain syndromes. Pain 1988; 33:273-87.
19. Simmons DG: Myofascial pain syndromes: Where we are? Where we are going? Arch Phys Med Renabil 1988; 69:207-12.
20. Simmons DG, Travell JG: Myofascial origins of low back pain. I. Principles of diagnosis and treatment. Postgrad Med 1983; 73:68-77.
21. Moldofsky H: Sleep-wake mechanisms in fibrositis. J Rheumatol 1989; 16(suppl 19):47-8.
22. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychossom Med 1976; 38: 35-44.
23. Wolfe F, Cathey MA: Prevalence of primary and secondary fibrositis (brief communication) J Rheumatol 1983; 10:965-8.
24. Middleton GD, McFarlin JE, Lipsky PE: The prevalence and clinical impact of fibromyalgia in systemic lupus erythematous. Arthritis Rheum 1994; 37:1181-8.
25. Hudson JI, Pope HG: The concept of affective spectrum disorder: Relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Bailliere's Clin Rheumatol 1994; 8:839-56.
26. Leventhal, LJ: Management of fibromyalgia. Ann Int Med 1999; 131(11) 850-8.
27. Wolfe F: Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 1989; 15:1-18.
28. Saskin P, Modolfsky H, Lue FA: Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome). Psychosom Med 1986; 48:319-23.
29. Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR et al: Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 1994; 37:794-800.
30. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA et al: Hypothalamic-pituitary-afrenal axis perturbations in patients with fibromyaigia. Arthritis Rheum 1994; 37:1583-92.
31. Modolfsky H: Rheumatic pain modulation syndrome: the interrelationship between sleep, central nervous system serotonin, and pain. Adv Neurol 1982; 33:51-7.
32. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE et al: Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994; 37:1593-601.
33. Goldstein JA, Mena I, Yunus MB: Regional cerebral flow by SPECT in chronic fatigue syndrome with and without fibromyalgia syndrome. Arthritis Rheum 1996; 36(9 suppl):S212.
34. Simms RW, Cahill L, Prashker M, Meenan RF: The direct costs of fibromyalgia treatment: comparison with rheumatoid arthritis and osteoarthritis. Journal of Musculoskeletal Pain 1995; 3:127-32.
35. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL et al: A prospective, longitudinal, multicente study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997,40:1560-70.
36. Felson DT, Goldenberg DL: The natural history of fibromyalgia. Arthritis Rheum 1986; 29:1522-6.
37. McCain GA, Bell DA, Mai FM, et al: A controlled study of the effects of a supervised cardiovascular fitness program on the manifestations of the primary fibromyalgia. Arthritis and Rheumatism PrimaryCare Review 1990; 2:1-15.
38. Mengshoel AM, Aomnaes HB, Forre O: The effect of 20 weeks of physical fitness in females with fibromyalgia. Clin Exp Rheumatol 1992; 10:345-9.
39. Deluze C, Bosia L, Zirbs A, et al: Eletroacupunture in fibromyalgia: Results of a controlled trial. BMJ 1992; 305:1249-52.
40. Nielson WR, Walker C, McCain GA: Cognitive behavioral treatment of fibromyalgia syndrome: Preliminary fidings. J Rheumatol 1992; 19:98-103.
41. Carrete S, Bell MJ, Reynolds WJ, Haraoul B, McCain GA, Bykerk VP, et al.: Comparision of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40.
42. Goldenberg DL, Mayskly M, Moosey C, Ruthazer R, Schmid C: A randomized, double-blind crossover trial of fluoxetine andamitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-9.
43. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparision of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum 1988; 31:1535-42.